How to transfer my Wellbutrin prescription to Illinois

If you’re struggling with Binge Eating Disorder (BED), you might be wondering whether you can access treatment from the comfort of your home. The short answer is yes—telehealth has become a legitimate, legal, and increasingly common way to receive care for BED, including prescription medications. But navigating the rules, understanding what’s available, and knowing what to expect can feel overwhelming.

This guide breaks down everything you need to know about getting BED medication through telehealth in 2025-2026, including current regulations, medication options, state-by-state differences, and how to find safe, effective care.

Understanding Binge Eating Disorder and Why Telehealth Matters

Binge Eating Disorder is the most common eating disorder in the United States, affecting millions of people. It’s characterized by recurring episodes of eating large amounts of food within a short period, feeling a loss of control during these episodes, and experiencing distress afterward—without the compensatory behaviors (like purging) seen in bulimia.

According to DSM-5 criteria, BED is diagnosed when someone experiences binge eating episodes at least once a week for three months, along with feelings of lack of control and significant distress about the behavior.

For many people with BED, accessing specialized treatment can be challenging. Eating disorder specialists may not be available locally, waitlists can stretch for months, and the stigma surrounding eating disorders can make it difficult to seek help in person. This is where telehealth becomes transformative—connecting patients with qualified providers regardless of geographic location, often with shorter wait times and greater privacy.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

The Legal Landscape: Can Doctors Prescribe BED Medications via Telehealth?

Federal Regulations: The Good News

Here’s the critical thing to understand: medications commonly used for Binge Eating Disorder—such as Topamax (topiramate) and Wellbutrin (bupropion)—are not controlled substances. This is excellent news for telehealth access.

The strict federal rules governing telemedicine prescribing (specifically the Ryan Haight Act) only apply to controlled substances like stimulants, opioids, and benzodiazepines. For non-controlled medications, there has never been a federal requirement for an in-person examination before prescribing via telehealth.

While the DEA has extended temporary flexibilities for controlled substance prescribing through December 31, 2026, these extensions don’t impact non-controlled medications—because those were already fully permissible via telehealth. As of January 2026, providers can legally prescribe Topamax, Wellbutrin, and other non-controlled BED treatments entirely through virtual visits in all 50 states, as long as they follow standard medical practices and state-specific requirements.

State-by-State Variations: What You Need to Know

While federal law sets the baseline, individual states can add their own telehealth requirements. The good news is that most states have either eliminated or significantly relaxed pandemic-era restrictions, making telehealth prescribing more accessible than ever.

States with No In-Person Requirement:

• California: Explicitly allows telehealth examinations (even asynchronous ones) to satisfy prescribing requirements as long as the standard of care is met
• New York: No in-person requirement for non-controlled medications
• Texas: Permits telehealth prescribing for non-controlled drugs without mandating face-to-face visits
• Florida: No in-person visit required for non-controlled prescriptions
• Michigan: Standard of care determines whether telehealth is appropriate; no specific in-person mandate
• Wisconsin: No in-person exam requirement for non-controlled medications

States with Periodic In-Person Requirements:

• Alabama: If you have more than four telehealth visits in 12 months for the same condition, an in-person visit within that year is required (though this can be with any collaborating provider)
• Georgia: Requires an attempt at an in-person exam at least annually for ongoing telemedicine care
• New Hampshire: For most medications, no in-person requirement; even for some controlled substances, only an annual in-person follow-up is needed

The vast majority of states allow you to start treatment entirely online, with follow-up care determined by your provider and clinical needs rather than arbitrary regulations.

Medications for Binge Eating Disorder: What’s Available via Telehealth

FDA-Approved Treatment

Only one medication is FDA-approved specifically for Binge Eating Disorder: Vyvanse (lisdexamfetamine). However, Vyvanse is a Schedule II controlled substance (a stimulant), which makes telehealth prescribing more complex and subject to those temporary DEA flexibilities that expire at the end of 2026.

Most legitimate telehealth platforms focus on alternative, non-controlled medications for BED due to the regulatory complexity and abuse potential of stimulants.

Off-Label Medications Commonly Prescribed via Telehealth

1. Topamax (Topiramate)

Topiramate is an anticonvulsant originally approved for seizures and migraine prevention, but research has shown it can be effective for reducing binge eating episodes and promoting weight loss.

How it works for BED: Topiramate appears to reduce impulsive behaviors and food cravings, though the exact mechanism isn’t fully understood. Studies have demonstrated reductions in binge frequency and body weight in patients with BED.

What to expect:

• Starting dose: Typically 25mg daily, gradually increased over weeks
• Target dose: Usually 100-200mg daily (lower than doses used for seizures)
• Supply: Providers can prescribe up to 90-day supplies with refills
• Monitoring: Regular check-ins to assess side effects, especially cognitive changes, tingling sensations, and metabolic effects

Important safety considerations:

• Pregnancy risk: Topiramate is linked to birth defects, particularly cleft palate. Effective contraception is essential for women of childbearing potential
• Gradual titration: Starting low and going slow helps minimize side effects
• Kidney stones: Increased risk; staying well-hydrated is important
• Cognitive effects: Some people experience difficulty with word-finding or concentration

2. Wellbutrin (Bupropion)

Bupropion is an antidepressant also used for smoking cessation, and it has shown benefit in reducing binge eating episodes in clinical studies.

How it works for BED: Bupropion affects dopamine and norepinephrine pathways, which may help regulate appetite and reduce the rewarding aspects of binge eating.

What to expect:

• Starting dose: Usually 150mg daily (sustained or extended release)
• Target dose: May increase to 300mg daily if needed
• Supply: Up to 90-day supplies with refills for up to one year
• Monitoring: Regular mood checks, blood pressure monitoring, and assessment of binge eating frequency

Important safety considerations:

• Seizure risk: Bupropion lowers the seizure threshold and is contraindicated in anyone with a current or past eating disorder involving purging (bulimia or anorexia), as these conditions increase seizure risk
• Black box warning: Like all antidepressants, bupropion carries a warning about increased suicidal thoughts in people under 25; close monitoring is required, especially when starting
• Alcohol: Avoid or minimize alcohol use (increases seizure risk)
• Blood pressure: Can raise blood pressure in some patients

Why Off-Label Prescribing is Standard Practice

Many patients worry when they learn their medication isn’t FDA-approved specifically for BED. Off-label prescribing is not only legal—it’s extremely common in medicine, especially in mental health and eating disorder treatment. In fact, most psychotropic medications are used off-label for various conditions.

What matters is that:

1. There’s clinical evidence supporting the medication’s use
2. Your provider explains the risks and benefits
3. You provide informed consent
4. The treatment is monitored appropriately

Both topiramate and bupropion have research backing their use in BED, and when prescribed thoughtfully, they represent evidence-based treatment options.

Who Can Prescribe BED Medications via Telehealth?

Medical Doctors and Doctors of Osteopathy

MDs and DOs can prescribe all BED medications via telehealth in every state, assuming they’re licensed in your state and follow telehealth best practices.

Nurse Practitioners (NPs)

The landscape for NP prescribing authority has expanded dramatically in recent years. As of 2025, 34 states plus the District of Columbia grant Nurse Practitioners Full Practice Authority (FPA), meaning they can evaluate patients and prescribe medications independently without physician oversight.

States where NPs have independent prescribing authority include:

• California (after 3 years of experience)
• New York (after 3,600 supervised hours)
• New Hampshire
• Michigan (as of 2025)
• Wisconsin (as of 2025)
• Delaware (after 2 years of collaboration)

In states with FPA, an NP can be your sole provider for BED treatment via telehealth, conducting evaluations and prescribing medications like Topamax or Wellbutrin without a physician’s involvement.

States requiring collaboration or supervision:

• Texas: NPs must have a prescriptive authority agreement with a physician
• Florida: NPs need a supervising physician protocol
• Georgia: Written collaborative agreement required
• Alabama: Physician collaboration required for all prescribing

In collaborative states, this doesn’t typically affect your care experience—it’s a behind-the-scenes regulatory requirement. The NP provides your direct care, with physician oversight built into the practice structure.

Physician Assistants (PAs)

PAs can also prescribe non-controlled medications like topiramate and bupropion in all states, though they work under varying levels of physician supervision depending on state law. Most telehealth platforms employ PAs alongside physicians and NPs as part of their provider teams.

The Telehealth Evaluation Process: What to Expect

Initial Consultation

A legitimate telehealth evaluation for BED should be comprehensive and thorough—typically 30-45 minutes for an initial visit. Be wary of any service that promises prescriptions after a 5-minute questionnaire.

Your provider will likely ask about:

• Detailed eating patterns and binge eating episodes (frequency, typical amounts, triggers)
• Feelings of control during eating episodes
• Emotional distress related to eating
• History of other eating disorders (critical for safety screening)
• Weight history and any previous weight loss attempts
• Medical history, including seizure disorders, cardiovascular issues, pregnancy status
• Mental health history (depression, anxiety, trauma)
• Current medications and supplements
• Family history of eating disorders or mental health conditions
• Social support and living situation
• Treatment goals and expectations

Diagnostic Criteria Assessment

Your provider will assess whether you meet DSM-5 criteria for Binge Eating Disorder:

• Recurrent episodes of binge eating (eating an unusually large amount within 2 hours)
• Feeling a lack of control during episodes
• Binge eating associated with three or more of: eating rapidly, eating until uncomfortably full, eating large amounts when not physically hungry, eating alone due to embarrassment, feeling disgusted/depressed/guilty afterward
• Marked distress about binge eating
• Occurring at least once weekly for three months
• Not accompanied by regular compensatory behaviors (purging, excessive exercise, fasting)

This assessment might include standardized questionnaires like the Binge Eating Scale (BES) or Eating Disorder Examination Questionnaire (EDE-Q).

Safety Screening

Your provider will screen for conditions that might make certain medications inappropriate:

For Wellbutrin:

• History of bulimia or anorexia (contraindication due to seizure risk)
• Personal or family history of seizures
• Conditions that lower seizure threshold
• Bipolar disorder (can trigger mania)

For Topamax:

• Pregnancy or pregnancy planning (teratogenic risk)
• Kidney disease or history of kidney stones
• Glaucoma
• Metabolic acidosis

Treatment Discussion

A good provider will discuss all treatment options, not just medication:

• Psychotherapy (especially Cognitive Behavioral Therapy or Dialectical Behavior Therapy)
• Nutritional counseling
• Support groups
• Lifestyle modifications
• Combination approaches

Medication should be presented as one tool in a comprehensive treatment approach, not a standalone solution.

Informed Consent

You’ll review and sign consent forms covering:

• Telehealth limitations and technology requirements
• Medication risks, benefits, and alternatives
• Off-label use acknowledgment (for Topamax and Wellbutrin)
• Privacy practices and how your information is protected
• Emergency protocols (what to do if you have a crisis)

Take time to read these documents and ask questions.

Prescription Monitoring and Follow-Up Care

Do Providers Check Prescription Monitoring Programs?

Most states maintain Prescription Drug Monitoring Programs (PDMPs) that track controlled substance prescriptions. For non-controlled medications like Topamax and Wellbutrin, PDMP checks are not legally required in any state.

However, providers may still review your medication history as part of good clinical practice—to check for potential drug interactions, duplicate therapy, or other safety concerns. This is a judgment call based on your individual situation.

Ongoing Monitoring

Initial phase (first 1-2 months):

• Check-ins every 2-4 weeks
• Dose titration based on response and side effects
• Monitoring for adverse reactions
• Assessment of binge eating frequency

Maintenance phase:

• Monthly or bimonthly visits
• Tracking symptom improvement
• Adjusting treatment as needed
• Screening for side effects

Annual requirements:Some states require periodic in-person visits for ongoing telehealth care (like Alabama’s 12-month rule or Georgia’s annual requirement), but these can often be satisfied by seeing any local provider for a physical exam, not necessarily your telehealth prescriber.

Refill Policies

Because these are non-controlled medications, providers can issue refills (typically up to 5 refills or 6 months, depending on state law). This means you won’t necessarily need a new prescription every month, though you’ll still have regular follow-up appointments.

How Klarity Health Approaches BED Treatment via Telehealth

When considering telehealth options for Binge Eating Disorder, it’s important to choose a platform that prioritizes safety, accessibility, and comprehensive care.

Klarity Health offers BED evaluations and treatment with several patient-centered advantages:

Provider Availability: Klarity maintains a network of licensed psychiatrists, psychiatric nurse practitioners, and therapists across multiple states, often with appointment availability within days rather than weeks or months.

Transparent Pricing: Klarity provides upfront pricing for both insurance and cash-pay options, so you know what to expect. Initial psychiatric evaluations and follow-up visits are clearly priced, with no surprise bills.

Flexible Payment Options: Whether you have insurance or prefer to pay out-of-pocket, Klarity accepts both. They work with major insurance plans and also offer competitive self-pay rates for those without coverage or with high deductibles.

Comprehensive Approach: Klarity providers take time for thorough evaluations (initial visits are typically 45 minutes) and discuss the full range of treatment options—not just medication. They can coordinate care with therapists and other providers as needed.

Licensed, Experienced Providers: All Klarity prescribers are fully licensed in the states where they practice and have experience treating eating disorders and related mental health conditions.

Red Flags: How to Spot Unsafe Telehealth Practices

The telehealth boom has brought both opportunity and risk. Some platforms cut corners on safety to maximize profits. Here’s what to watch for:

Warning Signs of Questionable Providers

❌ Prescription guarantees before evaluation: Any service that promises you’ll get medication before you’ve been properly assessed is prioritizing sales over safety.

❌ Superficial assessments: If the ‘evaluation’ is just a few yes/no questions taking less than 10 minutes, that’s not adequate medical care.

❌ No discussion of alternatives: Reputable providers discuss therapy, lifestyle changes, and other options—not just pills.

❌ Pressure to start treatment immediately: Good medicine involves informed decision-making, not high-pressure sales tactics.

❌ Selling medication directly: Legitimate services send prescriptions to regular pharmacies (CVS, Walgreens, mail-order). If a platform wants to ship you medication from their own warehouse, be very cautious.

❌ Avoiding follow-up: If there’s no structured follow-up plan, that’s a red flag. Ongoing monitoring is essential for safe medication management.

❌ No licensed prescriber contact: You should have direct communication with the actual prescriber (not just intake coordinators or ‘health coaches’).

What Good Telehealth Looks Like

✅ Thorough initial evaluation (30+ minutes)

✅ Licensed provider in your state who you can verify via state medical board

✅ Comprehensive informed consent process

✅ Discussion of risks, benefits, and alternatives

✅ Structured follow-up plan

✅ Clear emergency protocols

✅ Integration with regular pharmacies

✅ Transparent pricing

✅ Respect for your questions and concerns

Special Considerations and Common Questions

‘Will my insurance cover telehealth for BED medication?’

Most insurance plans now cover telehealth visits at the same rate as in-person visits for mental health and psychiatric services. The medications themselves (Topamax and Wellbutrin) are generally well-covered as they’re generic.

Check your plan’s telehealth policies and formulary. Klarity Health works with insurance companies to verify coverage before your appointment, so you understand your financial responsibility upfront.

‘I’m pregnant or planning to become pregnant. Can I still get treatment?’

Topiramate is contraindicated in pregnancy due to significant birth defect risks, particularly oral clefts. Most providers will not prescribe topiramate to pregnant patients or those planning pregnancy in the near future. Effective contraception is required when taking topiramate.

Bupropion has less clear pregnancy data but is generally avoided when possible. If you become pregnant while on either medication, contact your provider immediately—but don’t abruptly stop, especially with topiramate (seizure risk) or bupropion (withdrawal effects).

Treatment during pregnancy typically focuses on therapy-based approaches like CBT, with medication reserved for severe cases where benefits clearly outweigh risks.

‘I have a history of bulimia. Can I still use these medications?’

This requires careful evaluation:

Bupropion is contraindicated in anyone with a current or recent history of bulimia or anorexia due to seizure risk. This is an absolute contraindication in the FDA labeling.

Topiramate might be considered if your bulimia is in full remission and other risk factors are low, but this requires very careful assessment by your provider.

Always be completely honest about your eating disorder history—withholding this information could lead to dangerous prescribing.

‘What if I need therapy too?’

Medication works best when combined with psychotherapy for BED. Evidence-based therapies include:

• Cognitive Behavioral Therapy (CBT): Addresses thought patterns and behaviors around eating
• Dialectical Behavior Therapy (DBT): Focuses on emotional regulation and distress tolerance
• Interpersonal Psychotherapy (IPT): Explores relationship patterns and their connection to eating behaviors

Many telehealth platforms, including Klarity Health, offer both psychiatric medication management and therapy services, allowing you to work with providers who can coordinate your comprehensive care.

‘How long will I need to take medication?’

This varies by individual. Some people use medication for 6-12 months while developing new eating patterns and coping skills through therapy, then taper off. Others benefit from longer-term treatment.

Your provider will regularly reassess whether medication remains beneficial and appropriate for you.

‘What happens if the medication doesn’t work?’

If you don’t see improvement after an adequate trial (usually 2-3 months at therapeutic doses), your provider can:

• Adjust the dose
• Switch to a different medication
• Add another treatment modality
• Refer you to a higher level of care if needed

Not everyone responds to the same medications, and finding the right treatment sometimes requires patience and adjustment.

The Future of Telehealth for Eating Disorders

The regulatory environment continues to evolve, generally in the direction of greater access while maintaining safety standards:

DEA Permanent Rules: The DEA is expected to finalize permanent telehealth prescribing rules by the end of 2026. While these will primarily affect controlled substances, they’ll provide long-term clarity for the telehealth industry overall.

State Law Modernization: More states are updating telehealth laws to reflect post-pandemic realities, typically removing unnecessary barriers while maintaining appropriate safeguards.

NP Scope Expansion: The trend toward full practice authority for nurse practitioners continues, with several states considering legislation to grant or expand NP independence. This means greater access to experienced providers, especially in underserved areas.

Insurance Parity: Federal and state efforts to ensure telehealth payment parity with in-person care continue, making virtual treatment more financially accessible.

For patients with Binge Eating Disorder, these trends suggest that telehealth access will remain robust and may continue improving in the coming years.

Getting Started: Your Next Steps

If you’re ready to explore telehealth treatment for Binge Eating Disorder:

1. Research providers: Look for established platforms with licensed providers in your state. Verify that they offer comprehensive evaluations, not just quick prescriptions.

2. Check your insurance: Understand your telehealth coverage and whether the platform accepts your insurance or offers transparent self-pay pricing.

3. Prepare for your evaluation: Write down your eating patterns, symptoms, medical history, and questions. The more information you provide, the better your provider can help.

4. Be honest and thorough: Don’t minimize symptoms or withhold information about past eating disorders, mental health issues, or medication use. Complete honesty protects your safety.

5. Ask questions: Don’t leave your appointment with unanswered concerns. Ask about treatment alternatives, side effects, follow-up plans, and anything else on your mind.

6. Consider comprehensive treatment: Remember that medication is just one tool. Therapy, nutritional counseling, and support groups can all play important roles.

7. Follow up consistently: Stick with your scheduled appointments and communicate with your provider about how treatment is going.

Take the First Step Toward Recovery

Living with Binge Eating Disorder can feel isolating and overwhelming, but effective treatment is more accessible than ever. Telehealth has broken down many of the barriers that once kept people from getting help—geographic limitations, long waitlists, stigma, and scheduling challenges.

With proper evaluation and monitoring, medications like Topamax and Wellbutrin can be safely prescribed via telehealth to help reduce binge eating episodes while you develop healthier patterns through therapy and lifestyle changes. The regulations are clear: non-controlled BED medications can be legally and safely prescribed through telemedicine in all 50 states.

Whether you choose Klarity Health or another reputable platform, the important thing is taking that first step. You deserve support, effective treatment, and the opportunity to heal your relationship with food.

Ready to get started? Klarity Health offers comprehensive BED evaluations with experienced providers, flexible scheduling, and transparent pricing. With both insurance and self-pay options, treatment is accessible when you need it. Schedule your confidential evaluation today and begin your journey toward recovery.

Research Currency Statement

Verified as of: January 4, 2026

DEA Rules Status: COVID-19 telehealth prescribing flexibilities remain in effect through December 31, 2026 (fourth extension). No federal in-person requirement exists for non-controlled medications—these were never subject to the Ryan Haight Act restrictions on telemedicine.

States Verified: Researched 10+ key states (AL, CA, DE, FL, GA, NH, NY, TX, MI, WI, etc.) with latest information as of late 2025. State board sites and 2025 legislative updates were checked where available.

Sources Newer Than 2024: 80%+ of sources are from 2025 (many late-2025) or updated to 2025. Older sources (2024) were used only when confirmed still accurate by newer references.

Flagged for Follow-Up: Alabama and South Carolina NP scope changes (legislation was discussed in 2025 but final status unclear—assume no full independence yet pending confirmation). Monitor DEA’s pending final rule on telehealth prescribing (expected by end of 2026). Verify any temporary state waivers for expiration/extension beyond 2025.

Top Citations

1. HHS Press Release (January 2, 2026): DEA Extends Telemedicine Prescribing Flexibilities Through December 31, 2026. Available at: https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html

2. Sheppard Mullin Law Blog (August 2025): ‘Telehealth and In-Person Visits: Tracking Federal and State Updates to Pandemic-Era Telehealth Exceptions.’ Available at: https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/

3. Center for Connected Health Policy (December 2025): State Telehealth Policy Database – Online Prescribing. Available at: https://www.cchpca.org/topic/online-prescribing/

4. National Law Review (May 2025): ‘Telehealth and In-Person Visits: Tracking Federal and State Updates to Pandemic-Era Telehealth Exceptions.’ Available at: https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era

5. Health Jobs Nationwide Blog (2025): ‘State-by-State Guide: Expanding Roles for PAs and NPs (Updated 2025).’ Available at: https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=patients%20to%20receive%20prescriptions%20for,while%20permanent%20rules%20are%20finalized
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=extended%20telemedicine%20prescribing%20waivers%20through,prescribing
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=Full%20practice%20authority%20legislation%20reached,12
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=coordination%20with%20the%20U,prescribing
• https://telehealth.hhs.gov/providers/telehealth-policy/prescribing-controlled-substances-via-telehealth#:~:text=The%20Drug%20Enforcement%20Administration%20,through%20December%2031%2C%202025
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Prior%20to%20the%202024%20waiver,access%2C%20and%20diversion%20control%20measures
• https://www.cchpca.org/topic/online-prescribing/#:~:text=If%20a%20physician%20or%20practice,resolution%2C%20the%20physician%20shall%20either
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Prescribing%2C%20dispensing%2C%20or%20furnishing%20dangerous,the%20appropriate%20standard%20of%20care
• https://www.cchpca.org/topic/online-prescribing/#:~:text=constitutes%20unprofessional%20conduct,the%20appropriate%20standard%20of%20care
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=California%20leads%20the%20most%20important,12